Transferrin-conjugated Pluronic niosomes as a new drug delivery system for anticancer therapy

Langmuir

Volumn 29, Issue 41, 2013, Pages 12638-12646

  Tavano, Lorena ^a   Muzzalupo, Rita ^a   Mauro, Loredana ^a   Pellegrino, Michele ^a   Andò, Sebastiano ^a   Picci, Nevio ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-CANCER AGENTS; ANTI-CANCER THERAPIES; ANTICANCER ACTIVITIES; DELIVERY SYSTEMS; DOXORUBICIN HYDROCHLORIDE; DRUG DELIVERY SYSTEM; MDA-MB-231 CELLS; RECEPTOR-MEDIATED ENDOCYTOSIS;

CELL CULTURE; FLUORESCENCE MICROSCOPY; MOLECULAR BIOLOGY;

DRUG DELIVERY;

ANTINEOPLASTIC AGENT; DOXORUBICIN; LIPOSOME; PLURONIC L 64; POLOXAMER; TRANSFERRIN;

ARTICLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SCREENING; HUMAN; METHODOLOGY; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LIPOSOMES; MCF-7 CELLS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; POLOXAMER; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFERRIN;

EID: 84886881458     PISSN: 07437463     EISSN: 15205827     Source Type: Journal    
DOI: 10.1021/la4021383     Document Type: Article

References (57)

1. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer Cell 2000, 100, 57-70
2. Feng, S.; Chien, S. Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases Chem. Eng. Sci. 2003, 58, 4087-4114
3. Neri, D.; Bicknell, R. Nat. Rev. Cancer 2005, 5, 436-446
4. Rubert Nogueira, D.; Tavano, L.; Mitjans, M.; Pérez, L.; Infante, M. R.; Vinardell, M. P. Methotrexate-loaded pH-sensitive chitosan nanoparticles as a promising approach for an improved anticancer activity Biomaterials 2013, 4, 2758-2772
5. Forssen, E. A.; Coulter, D. M.; Proffitt, R. T. Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors Cancer Res. 1992, 52, 3255-3261
6. Haley, B.; Frenkel, E. Nanoparticles for drug delivery in cancer treatment Urol. Oncol.: Semin. Orig. Invest. 2008, 26, 57-64
7. Langer, R. Drug delivery and targeting Nature 1998, 392, 5-10
8. Torchilin, V. P. Drug targeting Eur. J. Pharm. Sci. 2000, 2, 81-91
9. Voinea, M.; Dragomir, E.; Manduteanu, I.; Simionescu, M. Binding and uptake of transferrin-bound liposomes targeted to transferring receptors of endothelial cells Vasc. Pharm. 2002, 39, 13-20
10. Simionescu, M.; Simionescu, N. Endothelial transport of macromolecules: Transcytosis and endocytosis. A look from cell biology Cell Biology Review 1991, 25, 1-80
11. Widera, A.; Norouziyan, F.; Shen, W. C. Mechanisms of TfR-mediated transcytosis and sorting in epithelial cells and applications toward drug delivery Adv. Drug Delivery Rev. 2003, 55, 1439-1466
12. Gatter, K. C.; Brown, G.; Trowbridge, I. S.; Woolston, R. E.; Mason, D. Y. Transferrin receptors in human tissues: Their distribution and possible clinical relevance J. Clin. Pathol. 1983, 36, 539-545
13. Hatakeyama, H.; Akita, H.; Maruyama, K.; Suhara, T.; Harashima, H. Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo Int. J. Pharm. 2004, 281, 25-33
14. Ishida, O.; Maruyama, K.; Tanahashi, H.; Iwatsuru, M.; Sasaki, K.; Eriguchi, M.; Yanagie, H. Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo Pharm. Res. 2001, 18, 1042-1048
15. Jiang, Y.; Liu, C.; Hong, M.; Zhu, S.; Pei, Y. Tumor cell targeting of transferrin-PEGTNF-α conjugate via a receptor-mediated delivery system: Design, synthesis, and biological evaluation Bioconjugate Chem. 2007, 1, 841-849
16. Kavimandan, N. J.; Losi, E.; Peppas, N. A. Novel delivery system based on complexation hydrogels as delivery vehicles for insulin-transferrin conjugates Biomaterials 2006, 27, 3846-3854
17. Singh, M. Transferrin as a targeting ligand for liposomes and anticancer drugs Curr. Pharm. Des. 1999, 5, 443-451
18. Kakudo, T.; Chaki, S.; Futaki, S.; Nakase, I.; Akaji, K.; Kawakami, T.; Maruyama, K.; Kamiya, H.; Harashima, H. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: An artificial viral-like delivery system Biochemistry 2004, 43, 5618-5628
19. Sahoo, S. K.; Ma, W.; Labhasetwar, V. Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer Int. J. Cancer 2004, 112, 335-340
20. Pan, X.; Guan, J.; Yoo, J. W.; Epstein, A. J.; Lee, L. J.; Lee, R. J. Cationic lipid-coated magnetic nanoparticles associated with transferrin for gene delivery Int. J. Pharm. 2008, 358, 263-270
21. Huang, R. Q.; Qu, Y. H.; Ke, W. L.; Zhu, J. H.; Pei, Y. Y.; Jiang, C. Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer FASEB J. 2007, 21, 1117-1125
22. Yeh, C. J. G.; Taylor, C. G.; Faulk, W. P. Killing of human tumor cells in culture with adriamycin conjugates of human transferring Peptides in Biological Fluids 1984, 32, 441-444
23. Soni, V.; Kohli, D. V.; Jain, S. K. Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-fluorouracil J. Drug Targeting 2005, 13, 245-250
24. Li, X. M.; Ding, L. Y.; Xu, Y.; Wang, Y.; Ping, Q. N. Targeted delivery of doxorubicin using stealth liposomes modified with transferring Int. J. Pharm. 2009, 373, 116-123
25. Omori, N. Targeting of post-ischemic cerebral endothelium in rat by liposomes bearing polyethylene glycolcoupled transferrin Neurol. Res. 2003, 25, 275-279
26. Photos, P. J.; Bacakova, L.; Discher, B.; Bates, F. S.; Discher, D. E. Polymer vesicles in vivo: Correlations with PEG molecular weight J. Controlled Release 2003, 90, 323-334
27. Maeda, H. The tumor blood vessel as an ideal target for macromolecular anticancer agents J. Controlled Release 1992, 19, 315-324
28. Mayer, L. D.; Tai, L. C.; Ko, D. S.; Masin, D.; Ginsberg, R. S.; Cullis, P. R.; Bally, M. B. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice Cancer Res. 1989, 49, 5922-5930
29. 3-PLA nanopolymersomes: Effect of solvents and process parameters on formulation development and in vitro study Mol. Pharmaceutics 2011, 8, 466-478
30. Discher, D. E.; Ortiz, V.; Srinivas, G.; Klein, M. L.; Kim, Y.; Christian, D.; Cai, S.; Photos, P.; Ahmed, F. Emerging applications of polymersomes in delivery: From molecular dynamics to shrinkage of tumors Prog. Polym. Sci. 2007, 32, 838-857
31. Kabanov, A. V.; Batrakova, E. V.; Alakhov, V. Y. Pluronic block copolymers for overcoming drug resistance in cancer Adv. Drug Delivery Rev. 2002, 54, 759-779
32. Woodle, M. C.; Newman, M. S.; Martin, F. J. Liposome leakage and blood circulation: Comparison of adsorbed block copolymers with covalent attachment of PEG Int. J. Pharm. 1992, 88, 327-334
33. Alakhov, V.; Klinski, E.; Li, S.; Pietrzynski, G.; Venne, A.; Batrakova, E.; Bronitch, T.; Kabanov, A. V. Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials Colloids Surf., B 1999, 16, 113-134
34. Miller, D. W.; Batrakova, E. V.; Kabanov, A. V. Inhibition of multidrug resistance-associated protein (MRP) functional activity with pluronic block copolymers Pharm. Res. 1999, 16, 396-401
35. Venne, A.; Li, S.; Mandeville, R.; Kabanov, A.; Alakhov, V. Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells Cancer Res. 1996, 56, 3626-3629
36. Bagrij, T.; Klokouzas, A.; Hladky, S. B.; Barrand, M. A. Influences of glutathione on anionic substrate efflux in tumour cells expressing the multidrug resistance-associated protein, MRP1 Biochem. Pharmacol. 2001, 62, 199-206
37. Erukova, V. Y.; Krylova, O. O.; Antonenko, Y. N.; Melik-Nubarov, N. S. Effect of ethylene oxide and propylene oxide block copolymers on the permeability of bilayer lipid membranes to small solutes including doxorubicin Biochim. Biophys. Acta 2000, 1468, 73-86
38. Muzzalupo, R.; Tavano, L.; Cassano, R.; Trombino, S.; Ferrarelli, T.; Picci, N. A new approach for the evaluation of niosomes as effective transdermal drug delivery systems Eur. J. Pharm. Biopharm. 2011, 79, 28-35
39. Bangham, A. D.; Standish, M. M.; Watkins, J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids J. Mol. Biol. 1965, 13, 238-252
40. Fenton, R. R.; Easdable, W. J.; Meng, H.; Omara, E. S. M.; Mckeage, M. J.; Russel, P. J.; Hambley, T. W. Preparation, DNA binding and in vitro cytotoxicity of a pair of enantiomeric platinum(II) complexes. [(R)- and (S)-3-aminohexahydroazepine]dichloro-platinum(II). Crystal structure of the S enantiomer J. Med. Chem. 1997, 40, 1090-1098
41. Provencher, S. W. Constrained regularization method for inverting data represented by linear algebraic or integral equations Comput. Phys. Commun. 1982, 27, 213-217
42. Tavano, L.; Gentile, L.; Oliviero Rossi, C.; Muzzalupo, R. Novel gel-niosomes formulations as multicomponent systems for transdermal drug delivery Colloids Surf., B 2013, 110, 281-288
43. Tavano, L.; Muzzalupo, R.; Trombino, S.; Cassano, R.; Pingitore, A.; Picci, N. Effect of formulations variables on the in vitro percutaneous permeation of sodium diclofenac from new vesicular systems obtained from pluronic triblock copolymers Colloids Surf., B 2010, 79, 227-234
44. Bendas, G.; Krause, A.; Schmidt, R.; Vogel, J.; Rothe, U. Selectins as new targets for immunoliposome-mediated drug delivery: A potential way of anti-inflammatory therapy Pharm. Acta Helv. 1998, 73, 19-26
45. Von Hoff, D. D.; Rozencweig, M.; Piccart, M. The cardiotoxicity of anticancer agents Semin. Oncol. 1982, 9, 23-33
46. Upadhyay, K. K.; Agrawal, H. G.; Upadhyay, C.; Schatz, C.; Le Meins, J. F.; Misra, A.; Lecommandoux, S. Role of block copolymer nanoconstructs in cancer therapy Crit. Rev. Ther. Drug Carrier Syst. 2009, 26, 157-205
47. Sanson, C.; Schatz, C.; Le Meins, J. F.; Soum, A.; Thévenot, J.; Garanger, E.; Lecommandoux, S. A simple method to achieve high doxorubicin loading in biodegradable polymersomes J. Controlled Release 2010, 147, 428-435
48. Upadhyay, K. K.; Bhatt, A. N.; Mishra, A. K.; Dwarakanath, B. S.; Jain, S.; Schatz, C.; Le Meins, J. F.; Farooque, A.; Chandraiah, G.; Jain, A. K.; Misra, A.; Lecommandoux, S. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(γ-benzyl l -glutamate)-b-hyaluronan polymersomes Biomaterials 2010, 31, 2882-2892
49. Bogner, J. R.; Goebel, F. D. In Stealth Liposomes; Lasic, D.; Martin, F., Eds.; CRC Press: Boca Raton, FL, 1995.
50. Iodoshima, N.; Udagawa, C.; Ando, T.; Fukuyasu, H.; Watanabe, H.; Nakabayashi, S. Lipid nanoparticles for delivering antitumor drugs Int. J. Pharm. 1997, 146, 81-92
51. Uchegbu, I. F. In Synthetic surfactant vesicles: Niosomes and other non-phospholipid vesicular systems; Harwood Academic: Amsterdam, 2000.
52. Muzzalupo, R.; Tavano, L.; Trombino, S.; Cassano, R.; Picci, N.; La Mesa, C. Niosomes from α,ω-trioxyethylene-bis(sodium 2-dodecyloxy- propylenesulfonate): Preparation and characterization Coll Surf., B 2008, 64, 200-207
53. Uchegbu, I.; Vyas, S. P. Non-ionic surfactant based vesicles (niosomes) in drug delivery Int. J. Pharm. 1998, 172, 33-70
54. Tavano, L.; Vivacqua, M.; Carito, V.; Muzzalupo, R.; Caroleo, M. C.; Nicoletta, F. Doxorubicin loaded magneto-niosomes for targeted drug delivery Colloids Surf., B 2013, 102, 803-807
55. Hong, M.; Zhu, S.; Jiang, Y.; Tang, G.; Pei, Y. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferring J. Controlled Release 2009, 133, 96-102
56. Gallois, L.; Fiallo, M.; Garnier-Suillerot, A. Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles. Circular dichroism study Biochim. Biophys. Acta 1998, 1370, 31-40
57. Crommelin, D. J. A.; van Bloois, L. Preparation and characterization of doxorubicin-containing liposomes. II. Loading capacity, long-term stability and doxorubicin-bilayer interaction mechanism Int. J. Pharm. 1983, 17, 135-144